Practice patterns and outcomes of direct oral anticoagulant use in myeloproliferative neoplasm patients

Myeloproliferative neoplasms (MPNs) are characterized by an increased risk of thrombosis and bleeding. Vitamin K antagonists (VKAs) are the historic anticoagulant recommended for use in MPNs. Direct oral anticoagulants (DOACs) are being increasingly used in general and cancer populations. However, D...

Descripción completa

Detalles Bibliográficos
Autores principales: How, Joan, Story, Charlotte, Ren, Siyang, Neuberg, Donna, Rosovsky, Rachel P., Hobbs, Gabriela S., Connors, Jean M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571422/
https://www.ncbi.nlm.nih.gov/pubmed/34741012
http://dx.doi.org/10.1038/s41408-021-00566-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571422/
https://www.ncbi.nlm.nih.gov/pubmed/34741012
http://dx.doi.org/10.1038/s41408-021-00566-5

Ejemplares similares